Dasatinib-responsive mast cell neoplasms as initial presentation of chronic myelogenous leukemia in blast phase

Carlos E. Vigil, Sa A. Wang, Jorge E. Cortes, Carlos Bueso-Ramos, Srdan Verstovsek, Roman Shinder, Su S. Chen, Ruth L. Katz, Abha Khanna, Bita Esmaeli, John T. Manning, M. James You, Roberto N. Miranda

Research output: Contribution to journalArticle

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)e514-e516
JournalJournal of Clinical Oncology
Volume29
Issue number17
DOIs
StatePublished - Jun 10 2011
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Vigil, C. E., Wang, S. A., Cortes, J. E., Bueso-Ramos, C., Verstovsek, S., Shinder, R., Chen, S. S., Katz, R. L., Khanna, A., Esmaeli, B., Manning, J. T., You, M. J., & Miranda, R. N. (2011). Dasatinib-responsive mast cell neoplasms as initial presentation of chronic myelogenous leukemia in blast phase. Journal of Clinical Oncology, 29(17), e514-e516. https://doi.org/10.1200/JCO.2010.34.1610